TACOMA, Wash. — A Tacoma pharmacy will pay $80,000 to resolve claims it failed to track controlled substances, the U.S. Attorney’s Office in Seattle announced Monday.
Lincoln Pharmacy reached a settlement with the U.S. Attorney’s Office after a Drug Enforcement Administration inspection found that the pharmacy didn’t comply with some requirements of the Controlled Substance Act.
During an inspection in June 2021, the DEA found that Lincoln Pharmacy failed to appropriately track and properly secure some controlled substances, including oxycodone and hydrocodone.
“The Controlled Substances Act has requirements for medical professionals and pharmacies so that certain narcotic substances are carefully tracked,” said U.S. Attorney Nick Brown in a news release. “Those requirements are designed to allow DEA to monitor the distribution of these drugs to try to combat abuse and addiction and the harms that follow.”
Lincoln is not admitting any liability as part of the settlement.
©2023 Cox Media Group
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/4AGIBED2JRBF3INSDB4FAAUEYA.png)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/SGVJEE4JJBCO5CPJ44P4K2452Q.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/HOA46ELYNZEBHEIIHUIEU7VHW4.png)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/L5Q3YQDRIJF5JNS7LDZTB2E32Q.jpeg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/XJZNXUQRV5ASNCAWBSF2T4WAME.jpg)